Author's Organization：Research Laboratory, Santen Pharmaceutical Co., Ltd. Research Laboratory, Santen Pharmaceutical Co., Ltd. Research Laboratory, Santen Pharmaceutical Co., Ltd. Research Laboratory, Santen Pharmaceutical Co., Ltd. Research Laboratory, Santen Pharmaceutical Co., Ltd.:(Present address)Laboratory of Chemistry and Department of Pharmacology, Osaka City University Medical School
A series of mercaptoacylamino acids was synthesized and screened as angiotensin I-converting enzyme inhibitors. The inhibitory activities of these compounds were compared with that of (2S)-1-[(2S)-3-mercapto-2-methylpropanoyl] proline. The structureactivity relationship of the compounds is discussed.
